AIRLINK 73.35 Decreased By ▼ -6.65 (-8.31%)
BOP 5.12 Decreased By ▼ -0.06 (-1.16%)
CNERGY 4.39 Decreased By ▼ -0.07 (-1.57%)
DFML 33.95 Decreased By ▼ -1.21 (-3.44%)
DGKC 75.85 Decreased By ▼ -1.03 (-1.34%)
FCCL 19.95 Decreased By ▼ -0.03 (-0.15%)
FFBL 36.35 Increased By ▲ 0.75 (2.11%)
FFL 9.34 Decreased By ▼ -0.19 (-1.99%)
GGL 9.91 Decreased By ▼ -0.25 (-2.46%)
HBL 116.85 Decreased By ▼ -0.15 (-0.13%)
HUBC 132.30 Decreased By ▼ -0.20 (-0.15%)
HUMNL 7.06 No Change ▼ 0.00 (0%)
KEL 4.50 Decreased By ▼ -0.15 (-3.23%)
KOSM 4.50 Decreased By ▼ -0.15 (-3.23%)
MLCF 36.53 Decreased By ▼ -0.97 (-2.59%)
OGDC 135.00 Increased By ▲ 0.53 (0.39%)
PAEL 22.75 Decreased By ▼ -0.15 (-0.66%)
PIAA 26.58 Decreased By ▼ -0.05 (-0.19%)
PIBTL 6.65 Decreased By ▼ -0.16 (-2.35%)
PPL 116.50 Increased By ▲ 4.40 (3.93%)
PRL 27.27 Increased By ▲ 0.07 (0.26%)
PTC 14.40 Increased By ▲ 0.02 (0.14%)
SEARL 55.58 Decreased By ▼ -0.81 (-1.44%)
SNGP 67.60 Increased By ▲ 0.60 (0.9%)
SSGC 10.77 Decreased By ▼ -0.06 (-0.55%)
TELE 8.79 Decreased By ▼ -0.50 (-5.38%)
TPLP 10.95 Decreased By ▼ -0.23 (-2.06%)
TRG 65.51 Decreased By ▼ -3.49 (-5.06%)
UNITY 25.12 Decreased By ▼ -0.37 (-1.45%)
WTL 1.31 Decreased By ▼ -0.01 (-0.76%)
BR100 7,546 Increased By 24.1 (0.32%)
BR30 24,527 Increased By 124.9 (0.51%)
KSE100 71,832 Increased By 137 (0.19%)
KSE30 23,617 Increased By 75.1 (0.32%)

KARACHI: NICVD denies all the allegations that any kind of treatment provided free at NICVD has been stopped. NICVD does all treatment based on medical evidences which currently shows that the survival benefits of angioplasty in only during heart attack (Primary Angioplasty) or in unstable Angina (heart attack knocking on the door), in these two conditions there is survival benefit with Angioplasty.

The evidences clearly show that Angioplasty in patients with Chronic Angina there is no survival benefit. There is only symptomatic benefit. Which can also be achieved with medicines. The benefit of Angioplasty for controlling of Angina is only when the medical treatment fails.

NICVD is World’s largest Centre for Primary Angioplasty. NICVD did more than 25,000 Primary Angioplasties and patients with unstable Angina in 2021. For Elective Angioplasty, NICVD has a heart team, which comprises Cardiac Surgeon and Interventional Cardiologists. The Heart team meets every day and decides if any patient’s medical treatment has failed that patient is referred for Elective Angioplasty and those are done totally free of cost.

NICVD continues to serve the people of Pakistan, providing state-of-the-art treatment to everyone. NICVD, which has 10 state-of-the-art hospitals and 23 Chest Pain Units, provide all sort of treatment totally free of cost, where medically indicated.

Copyright Business Recorder, 2022

Comments

Comments are closed.